{"id":"https://openalex.org/W1978783396","doi":"https://doi.org/10.1016/j.nmd.2010.07.151","title":"P3.09 The effect of combining activin receptor type IIB inhibition and prednisolone treatment in mdx mice","display_name":"P3.09 The effect of combining activin receptor type IIB inhibition and prednisolone treatment in mdx mice","publication_year":2010,"publication_date":"2010-09-05","ids":{"openalex":"https://openalex.org/W1978783396","doi":"https://doi.org/10.1016/j.nmd.2010.07.151","mag":"1978783396"},"language":"en","primary_location":{"id":"doi:10.1016/j.nmd.2010.07.151","doi":"https://doi.org/10.1016/j.nmd.2010.07.151","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.nmd.2010.07.151","pdf_url":null,"source":{"id":"https://openalex.org/S50004817","display_name":"Neuromuscular Disorders","issn_l":"0960-8966","issn":["0960-8966","1873-2364"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuromuscular Disorders","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041514565","display_name":"Jennifer L. Lachey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112018","display_name":"Acceleron Pharma (United States)","ror":"https://ror.org/023annq56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210112018"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.L. Lachey","raw_affiliation_strings":["Acceleron Pharma, Cambridge, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acceleron Pharma, Cambridge, United States","institution_ids":["https://openalex.org/I4210112018"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085072840","display_name":"Vicki L. Wong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112018","display_name":"Acceleron Pharma (United States)","ror":"https://ror.org/023annq56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210112018"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"V. Wong","raw_affiliation_strings":["Acceleron Pharma, Cambridge, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acceleron Pharma, Cambridge, United States","institution_ids":["https://openalex.org/I4210112018"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052288239","display_name":"Jasbir S. Seehra","orcid":"https://orcid.org/0009-0002-0843-8974","observed_orcids":["https://orcid.org/0009-0002-0843-8974"]},"institutions":[{"id":"https://openalex.org/I4210112018","display_name":"Acceleron Pharma (United States)","ror":"https://ror.org/023annq56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210112018"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Seehra","raw_affiliation_strings":["Acceleron Pharma, Cambridge, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acceleron Pharma, Cambridge, United States","institution_ids":["https://openalex.org/I4210112018"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210112018"],"apc_list":{"value":3470,"currency":"USD","value_usd":3470},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.08227938,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"20","issue":"9-10","first_page":"643","last_page":"643"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10441","display_name":"Muscle Physiology and Disorders","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10441","display_name":"Muscle Physiology and Disorders","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12400","display_name":"Neurogenetic and Muscular Disorders Research","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11724","display_name":"Inflammatory Myopathies and Dermatomyositis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/activin-receptor-type-iib","display_name":"ActRIIB","score":0.8889999985694885},{"id":"https://openalex.org/keywords/prednisolone","display_name":"prednisolone","score":0.9909999966621399},{"id":"https://openalex.org/keywords/duchenne-muscular-dystrophy","display_name":"Duchenne muscular dystrophy","score":0.9350000023841858},{"id":"https://openalex.org/keywords/mdx-mice","display_name":"mdx mice","score":0.9940000176429749},{"id":"https://openalex.org/keywords/glucocorticoid-combination-therapy","display_name":"glucocorticoid combination therapy","score":0.7229999899864197},{"id":"https://openalex.org/keywords/muscle-mass","display_name":"muscle mass","score":0.6710000038146973},{"id":"https://openalex.org/keywords/lean-body-mass","display_name":"lean body mass","score":0.8069999814033508},{"id":"https://openalex.org/keywords/muscle-strength","display_name":"muscle strength","score":0.7039999961853027},{"id":"https://openalex.org/keywords/handgrip-strength","display_name":"grip strength","score":0.8140000104904175},{"id":"https://openalex.org/keywords/muscle-function","display_name":"muscle function","score":0.4819999933242798},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.5590000152587891},{"id":"https://openalex.org/keywords/muscle-atrophy-prevention","display_name":"muscle atrophy prevention","score":0.3580000102519989}],"concepts":[{"id":"https://openalex.org/C2776715498","wikidata":"https://www.wikidata.org/wiki/Q11426176","display_name":"Prednisolone","level":2,"score":0.8443515300750732},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6854130029678345},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6618692874908447},{"id":"https://openalex.org/C2778943923","wikidata":"https://www.wikidata.org/wiki/Q1648484","display_name":"Duchenne muscular dystrophy","level":2,"score":0.6601930856704712},{"id":"https://openalex.org/C120863210","wikidata":"https://www.wikidata.org/wiki/Q17064264","display_name":"Lean body mass","level":3,"score":0.6319559216499329},{"id":"https://openalex.org/C2777433710","wikidata":"https://www.wikidata.org/wiki/Q5609571","display_name":"Grip strength","level":2,"score":0.5212141275405884},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4287458062171936},{"id":"https://openalex.org/C2779030066","wikidata":"https://www.wikidata.org/wiki/Q1137767","display_name":"Muscular dystrophy","level":2,"score":0.420445054769516},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38111746311187744},{"id":"https://openalex.org/C147583825","wikidata":"https://www.wikidata.org/wiki/Q620876","display_name":"Body weight","level":2,"score":0.2856235206127167},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.12856444716453552}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.nmd.2010.07.151","doi":"https://doi.org/10.1016/j.nmd.2010.07.151","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.nmd.2010.07.151","pdf_url":null,"source":{"id":"https://openalex.org/S50004817","display_name":"Neuromuscular Disorders","issn_l":"0960-8966","issn":["0960-8966","1873-2364"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuromuscular Disorders","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.4300000071525574,"display_name":"Zero hunger","id":"https://metadata.un.org/sdg/2"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1994788076","https://openalex.org/W1503096499","https://openalex.org/W2097680159","https://openalex.org/W2168426309","https://openalex.org/W3174532999","https://openalex.org/W2315804378","https://openalex.org/W4387307163","https://openalex.org/W2042954236","https://openalex.org/W1992476810","https://openalex.org/W2092419509"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2016-06-24T00:00:00"}